Latest news
{{'2026-06-03T06:00:52Z' | dateFormatFilter}}
Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care
{{'2026-05-27T13:00:00Z' | dateFormatFilter}}
Novo Nordisk advances cardiometabolic pipeline with new data featuring CagriSema and zenagamtide at the American Diabetes Association’s 2026 Scientific Sessions
{{'2026-05-26T08:41:00Z' | dateFormatFilter}}
Novo Nordisk global observational study reveals 2 in 5 people with cardiovascular disease have cardiovascular inflammation, increasing their risk of heart attack and stroke
Stay informed
Stay informed
Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.
